Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1983-04-29
1985-07-02
Wiseman, Thomas G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 514 42, 514 25, 2601125R, 260112R, 424 78, A61K 3700, A61K 3170, C07G 700, C07C10352
Patent
active
045268886
ABSTRACT:
This invention relates to the conjoint use of asparagine or aspartic acid polymers, e.g. poly-l-asparagine or poly-l-aspartic acid polymers, or copolymers thereof, with aminoglycoside antibiotics to inhibit the nephrotoxicity associated with aminoglycoside antibiotics.
REFERENCES:
patent: 3927204 (1975-12-01), Neri et al.
patent: 4356166 (1982-10-01), Peterson et al.
patent: 4409247 (1983-10-01), Baret et al.
Josepovitz et al., J. Pharm. and Exp. Ther. vol. 223, pp. 314-321, (1982).
Lipsky, J. J. J. Pharm. and Exp. Ther. vol. 215, pp. 390-393, (1980).
Kornguth et al. J. Antimicrobial Chemotherapy vol. 6, pp. 121-131, 1980.
Friedmann et al., Chemical Abstracts, vol. 94, No. 140387x, 1981 "Polymers with Potential Pharmacological Properties".
Hottendorf Girard H.
Williams Patricia D.
Bristol-Myers Company
Lloyd Richard R.
Teskin Robin
Wiseman Thomas G.
LandOfFree
Nephrotoxicity inhibitors for aminoglycoside antibiotics does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nephrotoxicity inhibitors for aminoglycoside antibiotics, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nephrotoxicity inhibitors for aminoglycoside antibiotics will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-381708